Fujian Rongji Software (002474.SZ) announced a forecasted net loss of 58-95 million yuan in 2024.
Rongji Software (002474.SZ) released its 2024 performance forecast, expecting a net profit attributable to shareholders of the listed company for the full year...
Fujian Rongji Software (002474.SZ) released its 2024 performance forecast, expecting a net loss of 58-95 million yuan for the full year attributable to the company's shareholders, a year-on-year decrease of 34.77%-60.18%.
During the reporting period, it is expected that the company's loss amount will significantly decrease compared to the same period last year, mainly due to the company accelerating project implementation progress. Operating income is expected to show a certain degree of growth compared to the same period last year. However, due to significant amortization and depreciation amounts, unexpected payments recovery, and other reasons, the company's net profit is still expected to be in loss. The company will further promote its business strategy of "industrialization, productization, and service-oriented" software, relying on its accumulated brand, team, products, technology, and other comprehensive advantages. The company will actively promote technological and business model innovation to further enhance its core competitiveness.
Related Articles

William Li: Chinese car companies are transitioning from single-point competition to system competition.

New stock news | Meedu once again submits application to the Hong Kong Stock Exchange to develop and provide comprehensive technology-driven marketing, sales, and operational support services.

New Stock News | Lanna Cheng submits again to the Hong Kong Stock Exchange, dedicated to the discovery, development, and commercialization of radiopharmaceuticals for cancer diagnosis and treatment.
William Li: Chinese car companies are transitioning from single-point competition to system competition.

New stock news | Meedu once again submits application to the Hong Kong Stock Exchange to develop and provide comprehensive technology-driven marketing, sales, and operational support services.

New Stock News | Lanna Cheng submits again to the Hong Kong Stock Exchange, dedicated to the discovery, development, and commercialization of radiopharmaceuticals for cancer diagnosis and treatment.

RECOMMEND





